Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
Clinical trial NCT03930641 · COMPLETED
Trial details
- NCT number
- NCT03930641
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2019-07-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.